Search - tctmd.com

Displaying 161 - 180 of 192

Sort: Relevancy | Date

Presentation ESC 2012

Vorapaxar for Secondary Prevention in Patients with Prior Myocardial Infarction

Presenter: 205474|Benjamin Scirica

August 26, 2012

News Conference News ESC 2012

Survey Reveals Improvements, Gaps in Primary PCI Access Across Europe

Jason Kahn

August 26, 2012

News Conference News ESC 2012

Prolonged Vorapaxar Enhances Secondary Prevention in Selected Post-MI Patients

August 26, 2012

News Conference News ESC 2012

Predictors of Aortic Regurgitation After TAVR Delineated

August 26, 2012

Presentation ESC 2012

Personalized antiplatelet treatment after percutaneous coronary intervention: The MADONNA study

Presenter: 159942|Jolanta Siller-Matula

August 26, 2012

News Conference News ESC 2012

Noninvasive CT-based FFR More Accurate than CT for Diagnosing Ischemic CAD

August 26, 2012

News Conference News ESC 2012

Niacin Holds No Surprise Side Effects But Efficacy Data Forthcoming

Caitlin E. Cox

August 26, 2012

News Conference News ESC 2012

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

Caitlin E. Cox

August 26, 2012

News Conference News ESC 2012

Comparable Long-Term Safety, Efficacy with Prasugrel, Clopidogrel in ACS

August 26, 2012

News Conference News

ESC Congress 2011: Drugs, Devices Work Together

Caitlin E. Cox

September 06, 2011

News Conference News

CRISP AMI: Balloon Pump Therapy Fails to Help STEMI Patients Without Shock

Jason Kahn

September 06, 2011

News Conference News

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

September 02, 2011

News Conference News

Landmark Analyses Show Downside of Prolonged Antiplatelet Therapy

September 02, 2011

News Conference News

Study Investigates Which Elderly Patients Benefit from Aggressive Treatment

September 01, 2011

News Conference News

Japanese ACS Patients Fare Better with High Rates of Intensive Treatment

September 01, 2011

News Conference News

Halting Clopidogrel in First Year Following Acute MI Hazardous

September 01, 2011

News Conference News

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

August 31, 2011

News Conference News

RESET: Largest Study to Date of Xience, Cypher Shows Noninferiority

August 31, 2011

News Conference News

Comprehensive French TAVI Registry Shows Promising Results

August 31, 2011

News Conference News

Long-term Antiplatelet Therapy: All Risk, No Benefit

August 30, 2011

Advertisement

Vorapaxar for Secondary Prevention in Patients with Prior Myocardial Infarction

Survey Reveals Improvements, Gaps in Primary PCI Access Across Europe

Prolonged Vorapaxar Enhances Secondary Prevention in Selected Post-MI Patients

Predictors of Aortic Regurgitation After TAVR Delineated

Personalized antiplatelet treatment after percutaneous coronary intervention: The MADONNA study

Noninvasive CT-based FFR More Accurate than CT for Diagnosing Ischemic CAD

Niacin Holds No Surprise Side Effects But Efficacy Data Forthcoming

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

Comparable Long-Term Safety, Efficacy with Prasugrel, Clopidogrel in ACS

ESC Congress 2011: Drugs, Devices Work Together

CRISP AMI: Balloon Pump Therapy Fails to Help STEMI Patients Without Shock

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

Landmark Analyses Show Downside of Prolonged Antiplatelet Therapy

Study Investigates Which Elderly Patients Benefit from Aggressive Treatment

Japanese ACS Patients Fare Better with High Rates of Intensive Treatment

Halting Clopidogrel in First Year Following Acute MI Hazardous

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

RESET: Largest Study to Date of Xience, Cypher Shows Noninferiority

Comprehensive French TAVI Registry Shows Promising Results

Long-term Antiplatelet Therapy: All Risk, No Benefit

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content